EntroGen Revenue and Competitors
Estimated Revenue & Valuation
- EntroGen's estimated annual revenue is currently $4.8M per year.
- EntroGen's estimated revenue per employee is $155,000
Employee Data
- EntroGen has 31 Employees.
- EntroGen grew their employee count by 15% last year.
EntroGen's People
Name | Title | Email/Phone |
---|---|---|
1 | Account Manager, Business Development | Reveal Email/Phone |
2 | Production Supervisor | Reveal Email/Phone |
3 | Quality Control Associate | Reveal Email/Phone |
4 | Research Associate | Reveal Email/Phone |
5 | Bioinformatics Scientist | Reveal Email/Phone |
6 | Validation Scientist II | Reveal Email/Phone |
7 | Customer Care Scientist-IVD | Reveal Email/Phone |
8 | Research Associate 2 | Reveal Email/Phone |
9 | Controller | Reveal Email/Phone |
10 | Production Lead | Reveal Email/Phone |
EntroGen Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is EntroGen?
EntroGen is a biotechnology company with a focus on molecular diagnostic products in the areas of hematology and oncology. EntroGen has a growing commercial portfolio of real-time PCR-based tests, with many of its products being used to guide and monitor targeted therapies for various malignancies. EntroGen’s footprint reaches every corner of the globe delivering reliable clinical and research products.
keywords:N/AN/A
Total Funding
31
Number of Employees
$4.8M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.2M | 31 | 7% | N/A |
#2 | $4.3M | 31 | 0% | N/A |
#3 | $3.5M | 31 | -3% | N/A |
#4 | $5.5M | 31 | 11% | N/A |
#5 | $5.4M | 32 | -6% | N/A |